Trial of oxytocin rest to reduce c-section
Part of Women’s health & pregnancy clinical trials.
This trial tests whether taking a break from oxytocin (a medicine used to strengthen contractions) can help reduce the chance of needing a C-section. It is for women whose labor has slowed down despite oxytocin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be carrying one baby who is head-down in the womb.
- You must be at least 36 weeks pregnant.
- Your labor has not progressed past 6 centimeters dilation after 8 hours since your water broke and while on oxytocin.
- You cannot have an infection in the amniotic sac or any condition that makes vaginal delivery unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if changing the mother's position during a long, slow labor can help speed things up. If your labor is not progressing as expected, you may be able to join and try different positions to see if they help.
This trial tests whether a continuous oxytocin infusion during a C-section helps maintain labor progress in people already receiving oxytocin. It may help reduce labor-related complications, but only if you meet the safety requirements for anesthesia and pregnancy conditions.
This study looks at how oxytocin, a medication that helps labor contractions, affects the second stage of labor. It may help researchers understand what leads to safer and smoother delivery for first-time mothers.
This trial compares giving oxytocin as a single injection versus a slow drip during C-sections in people at high risk for heavy bleeding after delivery. The goal is to find which method works better to prevent postpartum hemorrhage.
This trial tests oxytocin, a drug used to start or strengthen labor, in women who have given birth before and are being induced with a full-term, single baby. It aims to find the best way to use oxytocin safely and effectively.
This study compares two doses of oxytocin (a medicine given during cesarean section to prevent heavy bleeding) to see which works better for women with high-risk pregnancies. If you are having a planned cesarean and have certain risk factors, this trial may help find the best dose for you.
Hear when a new Prolonged Labor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.